Ph.D. GuidaDeepak Kaushik/Formulation Development, Optimization and Evaluation of Taste Masked Dosage Forms/Awarded-2015/http://hdl.handle.net/10603/302524 

1. Meenakshi Gupta/Development and Characterization of Nanoparticulate Drug Delivery for Anticancer drug(s)/Awarded -2018/http://hdl.handle.net/10603/406519 

2. Dharmender Rathee/Design, Synthesis and Biological Evaluation of Novel Anticancer Agents Targeting Matrix Metalloproteinases and Multidrug Resistance/Awarded  -2018/http://hdl.handle.net/10603/216044 

3. Neeta/Optimization, Development and Characterization of Nanoparticles of Boswellic Acids for Cancer Treatment/Awarded-2018/http://hdl.handle.net/10603/299372 

4. Seema Rohilla/Development and Characterization of Nanoliposomal Drug Delivery for an Anticancer Drug/Awarded-2018/http://hdl.handle.net/10603/298580 

5. Parijat Pandey/Development, Optimization and Evaluation of an Anticancer Drug Loaded Polymeric Nanoparticles/Awarded-2018/ 

6. Sunil/Central Composite Designed Solid Lipid Nanoparticles of Antitubercular drug(s) /Awarded-2019/http://hdl.handle.net/10603/299356 

7. Neeta Sharma/Pricing Regulation of Prescription Drug and its analysis across regulated and less regulated markets/Awarded-2020/http://hdl.handle.net/10603/329386 

8. Kripi Vohra/Formulation and Evaluation of Anticancer potential of Lens culinaris Medikus seeds/Awarded -2020/http://hdl.handle.net/10603/326442 

9. Reena Sheoran/Formulation of Nanoliposomes of Anticancer Drug using Pharmaceutical Experimental Design/Awarded-2021.

10. Sandeep Dhiman /A study on incessant coordination among global regulatory authorities and collaboration with pharmaceutical industry for selected products/Awarded 2021/http://hdl.handle.net/10603/362689

11. Mandeep Dahiya/Development, Optimization and Evaluation of Sorafenib Tosylate Loaded Superparamagnetic Nanoparticles for Anticancer Drug Delivery 

12. Virender Sachdeva/Formulation Development and Evaluation of Ananas Comosus for Anticancer Activity 

13. Harpreet Khanuja/Quality by Design Approach on Nanocarrier Delivery of Sorafenib: Formulation and in vitro Characterization

14. Anjali Saharan/Formulation Development and Evaluation of Terminalia Catappa Linn for Antidiabetic Potential 

15. Ajeet Pandey/Dissolution Enhancement of a BCS Class II Drug using QbD Approach 

16. Kirpa Shanker Tiwari/Development and evaluation of an improved osmotic controlled release tablets of metformin hydrochloride 

17. Nisha/Design, Optimization and Characterization of Nanoparticulate drug delivery system targeting respiratory disease(s) 

18. Priynka/Bioavailability enhancement of selected BCS class II drugs 

19. Tarif Hussain/A Study on Evolution of Digital Technology and its impact on Pharmaceutical Regulatory Environment 

20. Gagan Dua/ 

M. Pharm. Guidance

1. 2004-05/Ms. Deepti/Studies on novel techniques for improvement of dissolution rate and content uniformity using glibenclamide as a model drug.

2. 2005-06/Ms. Monika/Development of sustained release solid dispersion for soluble drug and sparingly soluble drug using factorial design.

3. 2006-07/Mr. Balwan Singh/Development and evaluation of porous solid dispersions of glimepiride using factorial design.

4. 2006-07/Mr. Devender/Generic Drugs: Global issues and regulatory control

5. 2007-08/Ms. Jyotsana/Study on influence of critical variables in high shear wet granulation on dissolution profile of furosemide.

6. 2007-08/Ms. Deepti Kaushik/Marketing authorization of generic drugs: global issues and challenges

7. 2008-09/Mr. Manjeet Kumar/Development and characterization of factorially designed 5-fluorouracil microspheres.

8. 2008-09/Ms. Ruchika Swami/BCS based biowaivers: regulatory issues and challenges

9. 2008-09/Mr. Dinesh Kumar/Regulatory aspects of Pharmaceutical excipients

10. 2009-10/Mr. Vipin Kumar/Permeability evaluation through chitosan membranes 

11. 2009-10/Mr. Dulichand/Drug approval process: Global issues and Regulatory control 

12. 2009-10/Ms. Neelam/Box-Behnken designed solid dispersions of Ezetimibe

13. 2010-11/Mr. Rattan Lal/5-FU Loaded chitosan nanoparticles

14. 2010-11/Mr. Jaideep/Bioanalytical method development and validation for the estimation of Olmesartan in Human Plasma using LC-MS/MS

15. 2010-11/Ms. Chetna/Prescription drug labeling: significance and regulatory requirements 

16. 2010-11/Mr. Vinod/Regulatory aspects of pharmaceutical impurities

17. 2011-12/Mr. Sandeep Goel/Method development for quantification of beta form of Imatinib mesylate using powder X-ray diffraction technique

18. 2011-12/Mr. Naresh Sarasar/Taste masking of levocetirizine dihydrochloride with ion exchange resin using factorial design.

19. 2011-12/Ms. Jyoti/Cosmetic regulations around the globe.

20. 2011-12/Ms. Vandana/Product Lifecycle Management in Pharmaceuticals: Regulatory issues and challenges.

21. 2011-12/Ms. Nidhi Garg/Preparation, optimization and characterization of Multifunctional directly co-processed excipient

22. 2011-12/Mr. Amit Kumar/Compromised anti-anxiety effect of non-benzodiazepines in stressed mice

23. 2012-13/Mr. Mohit Kumar/Formulation and characterization of gastroretentive floating tablets of famotidine hydrochloride using Box-Behnken design

24. 2012-13/Mr. Arun Kumar Chopra/Development of chitosan nanoparticles for ocular delivery of fluconazole using Box-Behnken design

25. 2012-13/Ms. Preeti Garg/Box-Behnken designed nanoparticle-in-microparticle (NiMS) system for formulating acetazolamide orally disintegrating tablets

26. 2012-13/Ms. Neelam Dalal/Recent challenges and strategies on deficiency response to fasten approval

27. 2012-13/Mr. Parveen Kumar/Regulatory pharmaceutical environment of emerging market: Unique challenges ahead

28. 2013-14/Mr. Parijat Pandey/Spray Dried Nanoparticles-in-Microparticles System (NiMS) for Formulating Acetazolamide in Orally Disintegrating Tablets Applying Central Composite Design (CCD). 

29. 2013-14/Mr. Mandeep Dahiya/Development and Characterization of Imatinib loaded Magnetic Nanoparticles using Pharmaceutical Experimental Design 

30. 2013-14/Ms. Rajni/Taste masking of bitter drugs using ion exchange resin

31. 2013-14/Ms. Manisha Saini/Recent challenges and opportunities in USA’s pharmaceutical regulatory landscape

32. 2013-14/Ms. Monika Punia/Regulatory consideration of quality by design and its implementation using shop floor case study

33. 2014-15/Ms. Dimple Chaudhary/Regulatory road map of medical devices in emerging markets

34. 2014-15/Ms. Komal Dhull/Regulatory intervention of outrageous cosmetics

35. 2014-15/Ms. Prerna Kaushik/Horizon scanning-drug pricing regulations of prescription drugs 

36. 2014-15/Ms. Priya Dhiman/Development and Characterization of atorvastatin loaded chitosan nanoparticles using central composite design

37. 2014-15/Mr. Vipin Malik/Formulation and characterization of gastroretentive floating tablets of allopurinol using central composite design

38. 2015-16/Ms. Reena/Formulation and evaluation of microspheres based oro-dispersible Roxithromycin tablets using central composite design

39. 2015-16/Ms. Beena Kumari/Formulation and characterization of gastro retentive floating tablet of atorvastatin calcium using central composite design

40. 2015-16/Mr. Vipin Malik/Formulation and characterization of gastro retentive floating tablet of allopurinol using central composite design

41. 2015-16/Mr. Jaidev/Nutraceuticals regulatory insights: Current scenario and future scope

42. 2016-17/Ms. Vriti /Regulatory aspects and policies related to development, evaluation and control of Nanopharmaceuticals

43. 2016-17/Ms. Ritika babbar/A cognitive of PLCM in pharma emerging markets regulatory environment 

44. 2016-17/Ms. Nidhi Saiwal/Formulation and characterization of simvastatin loaded polymeric nanoparticles using sonication technique

45. 2016-17/Mr. Gaurav Sharma/Dissolution enhancement of glibenclamide using solid dispersion technique by applying central composite design

46. 2017-18/Ms. Reena/Formulation and characterization of glimepiride nanoparticles for dissolution enhancement 

47. 2017-18/Ms. Anshul/Optimization of fenofibrate loaded nanocrystals for dissolution enhancement using central composite design

48. 2017-18/Mr. Aditya Kumar/The pre-mortem: Regulation for Biosimilars in USA, EU, Japan and India 

49. 2017-18/Mr. Raseshwar Banerjee/Bridging the Hive: Parenteral and ophthalmic regulatory filing

50. 2018-19/Ms. Pooja Mehra/Innovator and generic drugs: Uniqueness of Chinese and Japanese pharma regulations

51. 2018-19/Ms. Pooja Rathee/Mainstreaming 505(B) (2) in pharma environment

52. 2018-19/Ms. Nisha/Formulation and Characterization of Fenofibrate Loaded Nanoemulsion using High Shear Homogenisation Technique for Improvement of Solubility

53. 2018-19/Mr. Manish/Preparation, Optimization and Evaluation of Glimepiride Loaded Nanoemulsion using High Shear Homogenization Technique for Improvement of Solubility using Box-Behnken Design

54. 2019-20/Mr. Anurag Kumar/Formulation and Characterization of Rufinamide Nanosuspension For Improvement of Solubility

55. 2019-20/Ms. Doli Dagar/Formulation Of Letrozole Loaded Nanoemulsion 

56. 2019-20/Mr. Sumit Sanduria/Regulatory Challenges of Developing a Combination Product in a Globalized World 

57. 2019-20/Ms. Aman Kumari/Inspections, Warning Letters And Compliances: Global Regulatory Scenario 

58. 2020-21/Mr. Sushil Kashyap

59. 2020-21/Mr. Vikram

60. 2020-21/Mr. Nihal Singh/

61. 2020-21/Ms. Manisha Dalal